“This strategic acquisition integrates ASP Isotopes’ advanced enrichment technologies with Renergen’s established helium and natural gas operations, positioning the combined company to address escalating demand in high-technology sectors,” ASP said in a statement.
ASP noted that Renergen’s key asset is the Virginia gas project.
In September 2022, Renergen launched what it said was South Africa’s first commercial LNG production plant as part of the first phase of its Virginia gas and helium development.
Earlier this year, Renergen selected US-based Chart Industries and two other partners for the second phase of its helium and LNG project.
ASP said this project has benefited from $40 million of US government funding pursuant to a finance agreement with the US DFC and is expected to further benefit from an additional $500 million of senior debt funding from US DFC and a $250 million debt facility from Standard Bank to expand plant production capacity in South Africa.
The US DFC partners with the private sector to advance US foreign policy and strengthen national security by mobilizing private capital around the world, ASP noted.
According to Renergen’s website, Phase 1 of the project has been divided into three stages to allow for a measured startup while the plant ramps up to nameplate capacity of 2,560 MMBtu of LNG per day and around 75 mcf of liquid helium.
The second phase involves expanding its current operations through several key initiatives.
This includes drilling approximately 350-450 new productive wells, and constructing a natural gas gathering network of pipes.
Additionally, a significantly larger processing and liquefaction facility is planned, capable of producing 32,600 MMBtu per day of LNG and 894 mcf per day of liquid helium.
